Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Dier Mardi
Relationship:  
City:   South San Francisco
State:   CA
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   101,126    

Indirect Shares

   875      
Direct Value   $4,683,687    

Indirect Value

   $3,544      
Total Shares   102,001      
Total Value   $4,687,231      


Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,577,762 Acelyrin, Inc. $22,502 Madrigal Pharmaceuticals Inc $2,001,224 Adamas Pharmaceuticals Inc $82,200 Prelude Therapeutics Inc $0 Ultragenyx Pharmaceutical Inc $2,577,762 Acelyrin, Inc. $22,502 Madrigal Pharmaceuticals Inc $2,001,224
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    0   
    1    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   -2.0   
   1.0   
     Percentage Gain/Loss :
   -71.0%
 18.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Portola Pharmaceuticals Inc PTLA EVP and CFO 2020-07-02 0 0    Premium*  
            Adamas Pharmaceuticals Inc ADMS Director 2021-06-02 10,000 2020-06-03 0    Premium*  
            Prelude Therapeutics Inc PRLD Director 2020-09-29 10,000 2020-09-29 0    Premium*  
            Ultragenyx Pharmaceutical Inc RARE CFO & Executive Vice P... 2022-10-14 66,695 2020-10-12 0    Premium*  
            Acelyrin, Inc. SLRN CFO and CBO 2023-05-09 5,556 2023-05-09 875    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-03-11 8,875 0    Premium*  
* Premium Members only  

Records found :    73         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 3
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
PTLA Portola Pharmaceuticals I... EVP and CFO   •       –      –    2017-01-30 4 A $0.00 $0 D/D 15,625 15,625 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 OE $7.00 $78,095 D/D 10,235 4,300 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-03-15 4 AS $40.02 $409,605 D/D (10,235) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 OE $7.00 $1,736,009 D/D 93,392 6,885 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-06-27 4 AS $54.94 $5,179,825 D/D (93,392) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-07-11 4 OE $25.08 $585,618 D/D 23,350 23,350 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-07-11 4 AS $60.00 $1,401,000 D/D (23,350) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2017-08-16 4 D $54.86 $199,416 D/D (3,635) 0 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-01-31 4 A $0.00 $0 D/D 10,625 10,625 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-03-02 4 D $32.53 $219,090 D/D (6,735) 31,040 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-03-08 4 D $38.69 $483,531 D/D (12,474) 61,442 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-05-22 4 A $0.00 $0 D/D 5,859 118,785 0 -
PTLA Portola Pharmaceuticals I... Executive VP and CFO   •       –      –    2018-05-22 4 D $40.82 $102,621 D/D (2,514) 116,271 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-07-28 4 OE $0.00 $0 D/D 17,500 116,271 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-08-23 4 D $26.05 $229,084 D/D (8,794) 107,477 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-08-31 4 OE $0.00 $0 D/D 17,500 107,684 0 -
PTLA Portola Pharmaceuticals I... Interim Co-President & CFO   •       –      –    2018-09-04 4 D $29.18 $259,203 D/D (8,884) 98,800 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-12 4 A $0.00 $0 D/D 2,125 98,800 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-15 4 D $24.25 $21,049 D/D (868) 97,932 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-01-31 4 A $0.00 $0 D/D 18,750 116,682 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-03-04 4 D $33.41 $322,974 D/D (9,667) 107,219 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-04-04 4 AS $37.39 $1,513,824 D/D (40,486) 66,733 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-19 4 A $0.00 $0 D/D 5,859 72,592 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2019-05-20 4 D $28.69 $86,701 D/D (3,022) 69,570 0 -
PTLA Portola Pharmaceuticals I... EVP, CFO & CBO   •       –      –    2020-01-12 4 A $0.00 $0 D/D 2,125 69,995 0 -
  73  Records found
  1   2  3      
  Page 2 of 3  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us